Osteoarthritis, KneeNCT02077647
Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
An observational study of Osteoarthritis, Knee and Osteonecrosis, run by AO Clinical Investigation and Publishing Documentation at 4 sites in Japan.
Trial summary
The primary objective of this registry is to assess the functional outcome measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS) for patients with medial unicompartmental osteoarthritis and osteonecrosis of the knee treated conservatively. Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Osteoarthritis, Knee, Osteonecrosis
- How many people
- 20 participants
- Where
- 4 sitesJapan
- Study dates
- Mar 2014to Jul 2019
- How long will I take part?
- 24 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with Indication for open wedge HTO with the TomoFix™ Small presenting in the orthopaedic department of the participating hospitals
Who may be able to join
- 40 years of age and older
- Patients with OA Grade 1-4 (Kellgren-Lawrence) or osteonecrosis (ON) Stage 2-4 (according to the Koshino classification)
- Indication for open wedge HTO with the TomoFix™ Small
- No ligamental laxity
- Able to understand and read country national language at an elementary level
- Ability to understand the content of the patient information / informed consent form
- Willingness and ability to participate in the registry according to the registry plan (RP)
- Signed and dated IRB/EC-approved written informed consent
Who cannot join
- Femoro-tibial angle (FTA) > 190° (standing view x-ray)
- Flexion contracture > 15°
- Total knee replacement or unicompartmental knee on the contralateral side
- Infections located between the middle of the femur and the ankle
- Systemic bacterial infections
- Severe osteoarthritis or surgery of the hip joint
Show all 13Show fewer
- Smoking of more than 20 cigarettes per day
- Immunodeficiency or compromised host
- Patients who have participated in any other device or drug related clinical trial within the previous month
- ACL/PCL reconstruction of the same knee
- Severe osteoarthritis of the ipsilateral ankle joint
- HTO on the contralateral side
- Major surgery on both knees (minor surgery as arthroscopic meniscectomy and synovectomy is allowed)
Trial locations and contacts
4 sites in 1 country.
Japan4 sites
Nagasaki University
Nagasaki, 852-8501
Osaka Koseinenkin Hospital
Osaka, 553-0003
Hashiba Orthopaedic Clinic
Toyama, 939-8055
Toyama Municipal Hospital
Toyama, 939-8511
About this study
Official title: A Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
The primary objective of this registry is to assess the functional outcome measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS) for patients with medial unicompartmental osteoarthritis and osteonecrosis of the knee treated conservatively. The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study.
Read the detailed description
The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study.
The incidence of knee osteoarthritis (OA) is higher in Japan than in other populations. Respective prevalences of 47.0 and 70.2% in men and women for Kellgren-Lawrence Grades 2-4 knee OA are reported in Japanese patients aged 60 years and over.
First treatment options are pharmacological (i.e. NSAIDs) and non-pharmacological therapies (i.e. use of assistive devices, exercises, osteopathy, physical therapy), followed by injections of hyaluronic acid and other substances. If no such therapies are successful, surgical treatment options as unicompartmental knee replacement, total knee arthroplasty and high tibial osteotomy (HTO) are recognized. The discussion of which is the best therapy is still controversial. HTO may decrease the number of complications compared to total knee replacement or unicompartmental knee arthroplasty and leave the option for later replacement surgery.
In this project, patients are included who would be surgically treated with HTO with Tomofix small based on the investigator's assessment but refuse to have surgical treatment. They will be treated conservatively and are investigated to serve as reference to an ongoing clinical study investigating invasive treatment modalities.
- Conditions
- Osteoarthritis, Knee, Osteonecrosis
- Keywords
- Knee osteoarthritis, knee osteonecrosis, osteotomy
- Medical subject headings
- Osteoarthritis, Knee, Osteonecrosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Conservative | Conservative treatment of osteoarthritis of the knee |
What is being measured
The primary outcome is the main question the study is designed to answer.
Function of the knee
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Measured: 24 months
Secondary outcomes (12)
Patient-evaluated function of the knee and quality of life
Oxford-12-item knee score, WOMAC (as calculated from the KOOS)
Measured: 6 months, 12 months, 24 months
Clinician-evaluated function of the knee
Japanese Orthopaedic Association (JOA) score
Measured: 6 months, 12 months, 24 months
Health-related quality of life
Short Form-36 (SF-36)
Measured: 6 months, 12 months, 24 months
Range of motion (ROM)
Measured: 6 months, 12 months, 24 months
Local and general pain
Visual Analogue Scale (VAS)
Measured: 6 months, 12 months, 24 months
Possibility and duration of the Japanese sitting style
Measured: 6 months, 12 months, 24 months
Return to sport activities
Measured: 6 months, 12 months, 24 months
Utilization
Length of hospital stay
Measured: up to hospital discharge
Evaluation of degenerated and regenerated cartilage
ICRS and Outerbridge / Koshino)
Measured: intraoperative and after 2 years
Radiological parameters
Kellgren-Lawrence classification, joint space narrowing, tibial slope, tibia vara
Measured: 6 months, 12 months, 24 months
Complications
Complications due to injections, complications due to heat therapy, complications due to medication (NSAIDs)
Measured: 6 months, 12 months, 24 months
Anatomical alignment
Femoro tibial angle (FTA)
Measured: 6 months, 12 months, 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Mar 2014 (estimated)
- Study startMar 2014
- Primary completionApr 2015
- Study completionJul 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Osteoarthritis, KneeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 20 participants (actual)
- Target duration
- 24 Months
Sponsor and investigators
- Lead sponsor
- AO Clinical Investigation and Publishing Documentation
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Andreas Faeh, Study director, AO Clinical Investigation and Documentation, Davos, SwitzerlandTakeshi Sawaguchi, MD, Principal investigator, Toyama Municipal Hospital, Toyama-city, Japan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02077647
- Sponsor's protocol ID
- FR_Tomofix
- Status last verified
- Aug 2020
- First submitted
- 12 Feb 2014
- Last updated
- 12 Aug 2020
- Results posted
- No
- Data monitoring committee
- No
Publications
Takeuchi R, Aratake M, Bito H, Saito I, Kumagai K, Hayashi R, Sasaki Y, Akamatsu Y, Ishikawa H, Amakado E, Aota Y, Saito T. Clinical results and radiographical evaluation of opening wedge high tibial osteotomy for spontaneous osteonecrosis of the knee. Knee Surg Sports Traumatol Arthrosc. 2009 Apr;17(4):361-8. doi: 10.1007/s00167-008-0698-4. Epub 2009 Jan 23.
PubMed 19165468Takeuchi R, Ishikawa H, Aratake M, Bito H, Saito I, Kumagai K, Akamatsu Y, Saito T. Medial opening wedge high tibial osteotomy with early full weight bearing. Arthroscopy. 2009 Jan;25(1):46-53. doi: 10.1016/j.arthro.2008.08.015. Epub 2008 Oct 10.
PubMed 19111218Takeuchi R, Saito T, Koshino T. Clinical results of a valgus high tibial osteotomy for the treatment of osteoarthritis of the knee and the ipsilateral ankle. Knee. 2008 Jun;15(3):196-200. doi: 10.1016/j.knee.2008.02.002. Epub 2008 Mar 25.
PubMed 18367399
Study at a glance
From the registry record, last updated by the sponsor on 12 Aug 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
- ClinicalTrials.gov ID
- NCT02077647
- Acronym / sponsor ID
- FR_Tomofix
- Conditions
- Osteoarthritis, Knee, Osteonecrosis
- Keywords
- Knee osteoarthritis, knee osteonecrosis, osteotomy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- AO Clinical Investigation and Publishing DocumentationUniversity, hospital or other
- Study start
- Mar 2014
- Primary completion
- Apr 2015 (actual)
- Study completion
- Jul 2019 (actual)
- First posted
- 4 Mar 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this registry is to assess the functional outcome measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS) for patients with medial unicompartmental osteoarthritis and osteonecrosis of the knee treated conservatively. The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study.
Detailed description
The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study.
The incidence of knee osteoarthritis (OA) is higher in Japan than in other populations. Respective prevalences of 47.0 and 70.2% in men and women for Kellgren-Lawrence Grades 2-4 knee OA are reported in Japanese patients aged 60 years and over.
First treatment options are pharmacological (i.e. NSAIDs) and non-pharmacological therapies (i.e. use of assistive devices, exercises, osteopathy, physical therapy), followed by injections of hyaluronic acid and other substances. If no such therapies are successful, surgical treatment options as unicompartmental knee replacement, total knee arthroplasty and high tibial osteotomy (HTO) are recognized. The discussion of which is the best therapy is still controversial. HTO may decrease the number of complications compared to total knee replacement or unicompartmental knee arthroplasty and leave the option for later replacement surgery.
In this project, patients are included who would be surgically treated with HTO with Tomofix small based on the investigator's assessment but refuse to have surgical treatment. They will be treated conservatively and are investigated to serve as reference to an ongoing clinical study investigating invasive treatment modalities.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Target follow-up
- 24 Months
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Conservative | – | –Conservative treatment of osteoarthritis of the knee |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with Indication for open wedge HTO with the TomoFix™ Small presenting in the orthopaedic department of the participating hospitals
Key inclusion criteria (8 listed)
- 40 years of age and older
- Patients with OA Grade 1-4 (Kellgren-Lawrence) or osteonecrosis (ON) Stage 2-4 (according to the Koshino classification)
- Indication for open wedge HTO with the TomoFix™ Small
- No ligamental laxity
- Able to understand and read country national language at an elementary level
Key exclusion criteria (13 listed)
- Femoro-tibial angle (FTA) > 190° (standing view x-ray)
- Flexion contracture > 15°
- Total knee replacement or unicompartmental knee on the contralateral side
- Infections located between the middle of the femur and the ankle
- Systemic bacterial infections
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Function of the knee
Time frame: 24 months
Knee Injury and Osteoarthritis Outcome Score (KOOS)
12 secondary outcomes
Patient-evaluated function of the knee and quality of life
Time frame: 6 months, 12 months, 24 months
Clinician-evaluated function of the knee
Time frame: 6 months, 12 months, 24 months
Health-related quality of life
Time frame: 6 months, 12 months, 24 months
Range of motion (ROM)
Time frame: 6 months, 12 months, 24 months
Local and general pain
Time frame: 6 months, 12 months, 24 months
Possibility and duration of the Japanese sitting style
Time frame: 6 months, 12 months, 24 months
Return to sport activities
Time frame: 6 months, 12 months, 24 months
Utilization
Time frame: up to hospital discharge
Evaluation of degenerated and regenerated cartilage
Time frame: intraoperative and after 2 years
Radiological parameters
Time frame: 6 months, 12 months, 24 months
Complications
Time frame: 6 months, 12 months, 24 months
Anatomical alignment
Time frame: 6 months, 12 months, 24 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Aug 2020.
- Background: PubMed 19165468Takeuchi R, Aratake M, Bito H, Saito I, Kumagai K, Hayashi R, Sasaki Y, Akamatsu Y, Ishikawa H, Amakado E, Aota Y, Saito T. Clinical results and radiographical evaluation of opening wedge high tibial osteotomy for spontaneous osteonecrosis of the knee. Knee Surg Sports Traumatol Arthrosc. 2009 Apr;17(4):361-8. doi: 10.1007/s00167-008-0698-4. Epub 2009 Jan 23.
- Background: PubMed 19111218Takeuchi R, Ishikawa H, Aratake M, Bito H, Saito I, Kumagai K, Akamatsu Y, Saito T. Medial opening wedge high tibial osteotomy with early full weight bearing. Arthroscopy. 2009 Jan;25(1):46-53. doi: 10.1016/j.arthro.2008.08.015. Epub 2008 Oct 10.
- Background: PubMed 18367399Takeuchi R, Saito T, Koshino T. Clinical results of a valgus high tibial osteotomy for the treatment of osteoarthritis of the knee and the ipsilateral ankle. Knee. 2008 Jun;15(3):196-200. doi: 10.1016/j.knee.2008.02.002. Epub 2008 Mar 25.
Related trials for Osteoarthritis, Knee
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
RecruitingObservational study
Exploring Factors Linked to Worsening Over Time in People With Early-stage Knee Osteoarthritis and Those With Prior Proven Acute Knee Injury.
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Andreas Faeh study director
AO Clinical Investigation and Documentation, Davos, Switzerland
Takeshi Sawaguchi, MD principal investigator
Toyama Municipal Hospital, Toyama-city, Japan
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Osteoarthritis, Knee and Osteonecrosis, run by AO Clinical Investigation and Publishing Documentation at 4 sites in Japan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in Japan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Function of the knee (time frame: 24 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02077647, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2020.